HHC
CNMD icon

Hutchin Hill Capital’s CONMED CNMD Stock Holding History

Hutchin Hill Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-8,500
Closed -$446K – 449
2017
Q3 		$446K Sell
8,500
-15,771
-65% -$792K 0.02% 564
2017
Q2 		$1.24M Buy
+24,271
New +$1.2M 0.04% 450

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hutchin Hill Capital's CNMD Position: Q4 2017 in Review

Hutchin Hill Capital sold out of CONMED (CNMD) in Q4 2017, closing a stake of 8,500 shares — an estimated $446K sold.

Hutchin Hill Capital first reported a position in CNMD in Q2 2017 and held it in 2 quarters. The position peaked at $1.24M in Q2 2017. 160 funds tracked by Wall St. Rank hold CNMD as of Q4 2017.

  • Hutchin Hill Capital reported no remaining CONMED position as of Q4 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 8,500 CONMED shares in Q4 2017, an estimated $446K.
  • Hutchin Hill Capital first reported a position in CONMED in Q2 2017 and held it in 2 quarters.
  • Hutchin Hill Capital's CONMED position peaked at $1.24M in Q2 2017.
  • 160 funds tracked by Wall St. Rank held CONMED as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.